(19)
(11) EP 1 940 373 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.06.2015 Bulletin 2015/26

(45) Mention of the grant of the patent:
06.05.2015 Bulletin 2015/19

(21) Application number: 06850456.2

(22) Date of filing: 13.10.2006
(51) International Patent Classification (IPC): 
A61K 31/045(2006.01)
A61K 31/075(2006.01)
 A61K 31/047(2006.01)
A61P 25/28(2006.01)
(86) International application number:
PCT/IB2006/004181
(87) International publication number:
WO 2007/119108 (25.10.2007 Gazette 2007/43)

(54)

1-FLUORO-1-DEOXY-SCYLLO-INOSITOL FOR THE TREATMENT OF ALZHEIMER'S DISEASE

1-FLUORO-1-DEOXY-SCYLLO-INOSITOL ZUR BEHANDLUNG VON ALZHEIMER'SCHE KRANKHEIT

1-FLUORO-1-DEOXY-SCYLLO-INOSITOL DESTINE AU TRAITEMENT DE LA MALADIE D'ALZHEIMER

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 13.10.2005 US 725634 P

(43) Date of publication of application:
09.07.2008 Bulletin 2008/28

(73) Proprietor: Waratah Pharmaceuticals, Inc.
Toronto, ON M5G 1L7 (CA)

(72) Inventors:
  • CRUZ, Antonio
    Toronto, Ontario M5P 2T7 (CA)
  • KURDYDYK, Linda
    Toronto, Ontario M4R 1H3 (CA)

(74) Representative: Harding, Charles Thomas et al
D Young & Co LLP 120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)


(56) References cited: : 
WO-A-2007/041855
WO-A1-2004/075882
CA-A1- 2 214 635
 WO-A-2007/134449
WO-A1-2006/053428
CA-A1- 2 486 663
   
  • SUN Y ET AL: "Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 16, no. 15, 1 August 2008 (2008-08-01), pages 7177-7184, XP023610694, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2008.06.045 [retrieved on 2008-06-26]
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).